生理性起搏与右心室起搏对左室射血分数>35%患者的影响:系统评价
该系统评价纳入8项研究共679例左室射血分数>35%且需永久起搏的心脏传导阻滞患者,比较双心室起搏或希氏束起搏与右心室起搏的效果。结果显示生理性起搏组左室舒张末期和收缩末期容积显著降低,左室射血分数保持或增加;临床结局改善主要见于合并慢性房颤且行房室结消融的患者。
要点
- 左室射血分数>35%患者中,生理性起搏较右心室起搏显著降低左室容积并保持或改善左室射血分数。
- 临床结局(功能状态、生活质量)改善证据不明确,住院数据不可用,死亡率无差异。
- 慢性房颤行房室结消融并起搏者,双心室或希氏束起搏较右心室起搏明显改善左室射血分数。
核心结论
- 在左室射血分数>35%的患者中,双心室起搏或希氏束起搏较右心室起搏可保持或增加左室射血分数。
- 以患者为中心的临床结局改善主要限于合并慢性房颤、快速心室率且已行房室结消融的患者。
研究设计与样本
- 系统评价,检索MEDLINE(通过PubMed)和Embase,纳入比较双心室起搏或希氏束起搏与右心室起搏的随机试验和观察性研究进行荟萃分析。
- 共纳入8项研究、679例符合预设纳入标准的患者。
- 因行业程序限制无法获取左室射血分数>35%和≤35%患者混合报告的未发表亚组数据,此类研究未纳入荟萃分析。
主要发现
- 生理性起搏(双心室起搏或希氏束起搏)组左室舒张末期容积平均随访1.64年时较右心室起搏显著降低-2.77 mL(95%CI -4.37至-1.1 mL,p=0.001)。
- 左室收缩末期容积平均随访1.64年时显著降低-7.09 mL(95%CI -11.27至-2.91 mL,p=0.0009)。
- 左室射血分数平均随访1.57年时保持或增加5.328%(95%CI 2.86%至7.8%,p<0.0001)。
- 功能状态和生活质量等临床影响数据不明确,住院数据不可用,死亡率无影响。
- 多项研究按左室射血分数分层发现,左室射血分数>35%但≤52%的患者更可能从生理性起搏获益。
临床怎么用
- 对于左室射血分数>35%且需永久起搏的心脏传导阻滞患者,可考虑双心室起搏或希氏束起搏以减轻右心室起搏相关的不良重构。
- 慢性房颤伴快速心室率行房室结消融并起搏的患者,优先考虑双心室起搏或希氏束起搏。
- 左室射血分数>35%但≤52%的患者可能从生理性起搏中获益更多,决策时可参考。
局限性
- 证据来自8项研究共679例患者,样本量有限。
- 功能状态、生活质量和住院等临床结局数据不明确或不可用。
- 未能纳入左室射血分数>35%和≤35%患者混合报告的未发表亚组数据,可能引入选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is unclear whether physiologic pacing by either cardiac biventricular pacing (BiVP) or His bundle pacing (HisBP) may prevent adverse structural and functional consequences known to occur among some patients who receive right ventricular pacing (RVP). AIM: Our analysis sought to review existing literature to determine if BiVP and/or HisBP might prevent adverse remodeling and be associated with structural, functional, and clinical advantages compared with RVP among patients without severe left ventricular dysfunction (>35%) who required permanent pacing because of heart block. METHODS: A literature search was conducted using MEDLINE (through PubMed) and Embase to identify randomized trials and observational studies comparing the effects of BiVP or HisBP versus RVP on measurements of left ventricular dimensions, left ventricular ejection fraction (LVEF), heart failure functional classification, quality of life, 6-minute walk, hospitalizations, and mortality. Data from studies that met the appropriate population, intervention, comparator, and outcomes of interest were abstracted for meta-analysis. Studies that reported pooled outcomes among patients with LVEF both above and below 35% could not be included in the meta-analysis because of strict relationships with industry procedures that preclude retrieval of industry-retained unpublished data on the subset of patients with preserved left ventricular function. RESULTS: Evidence from 8 studies, including a total of 679 patients meeting the prespecified criteria for inclusion, was identified. Results were compared for BiVP versus RVP, HisBP versus RVP, and BiVP+HisBP versus RVP. Among patients who received physiologic pacing with either BiVP or HisBP, the LV end-diastolic and end-systolic volumes were significantly lower (mean duration of follow-up: 1.64 years; -2.77 mL [95% CI -4.37 to -1.1 mL]; p=0.001; and -7.09 mL [95% CI -11.27 to -2.91; p=0.0009) and LVEF remained preserved or increased (mean duration of follow-up: 1.57 years; 5.328% [95% CI: 2.86%-7.8%; p<0.0001). Data on clinical impact such as functional status and quality of life were not definitive. Data on hospitalizations were unavailable. There was no effect on mortality. Several studies stratified results by LVEF and found that patients with LVEF >35% but ≤52% were more likely to receive benefit from physiologic pacing. Patients with chronic atrial fibrillation who underwent atrioventricular node ablation and pacemaker implant demonstrated clear improvement in LVEF with BiVP or HisBP versus RVP. CONCLUSION: Among patients with LVEF >35%, the LVEF remained preserved or increased with either BiVP or HisBP compared with RVP. However, patient-centered clinical outcome improvement appears to be limited primarily to patients who have chronic atrial fibrillation with rapid ventricular response rates and have undergone atrioventricular node ablation.
引用
- Slotwiner DJ, Raitt MH, Del-Carpio Munoz F, et al. Impact of Physiologic Pacing Versus Right Ventricular Pacing Among Patients With Left Ventricular Ejection Fraction Greater Than 35%: A Systematic Review for the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018. PMID: 30412708. doi:10.1016/j.jacc.2018.10.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。